Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A **triplet excited state** refers to an *electronic excited state* of an atom or molecule in which two electrons occupy molecular orbitals with **parallel spins**, resulting in a total spin quantum number (S) of 1. This state is called a “triplet” because it has three possible spin projections (m_S = –1, 0, +1). The triplet excited state generally arises after photoexcitation and subsequent intersystem crossing from an excited singlet state. Unlike typical biological targets such as receptors, enzymes, or ion channels, the triplet excited state represents a generic *quantum mechanical property* of molecules rather than a specific, actionable biological molecule. This state is critical in understanding **phenomena like phosphorescence** and reactivity in photochemistry. In some contexts, such as organic semiconductors or photodynamic therapy, the triplet excited state of specific molecules (e.g., photosensitizers or drugs) can participate in chemical reactions, energy transfer, or the generation of reactive oxygen species, but the term itself does not denote a unique molecular entity[1][7][4][9][5]. Caveats: - "Triplet excited state" is a **physical state, not a discrete molecule or receptor**. It describes a condition of an electron arrangement rather than a protein, enzyme, or pharmacological target. - **Not a canonical therapeutic target**, though specific molecules in their triplet states may participate in drug mechanisms (e.g., in photodynamic therapy or as part of a photophysics-based assay)[1][2][8]. - No standard abbreviation is widely used; "T1" refers to the lowest-energy triplet state for a molecule, but this is not considered a canonical abbreviation for a molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Triplet excited state.